Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stimulants for ADHD in Children with FASD
NCT04968522Phase 4Unknown
- Sponsor
- Monash Medical Centre
- Start
- Feb 2022
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet, dextroamphetamine in attention deficit hyperactivity disorder (ADHD), sponsored by Monash Medical Centre. Status: unknown.
02
Drugs
methylphenidate hydrochloride extended-release chewable tabletdextroamphetamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT04968522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04968522.